274 related articles for article (PubMed ID: 16763797)
1. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
[TBL] [Abstract][Full Text] [Related]
2. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
[TBL] [Abstract][Full Text] [Related]
3. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG
Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006
[TBL] [Abstract][Full Text] [Related]
4. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
Vorob'eva IV
Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427
[TBL] [Abstract][Full Text] [Related]
5. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
6. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
Berthet P; Farine JC; Barras JP
Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760
[TBL] [Abstract][Full Text] [Related]
7. Calcium dobesilate reduces endothelin-1 and high-sensitivity C-reactive protein serum levels in patients with diabetic retinopathy.
Javadzadeh A; Ghorbanihaghjo A; Adl FH; Andalib D; Khojasteh-Jafari H; Ghabili K
Mol Vis; 2013; 19():62-8. PubMed ID: 23335852
[TBL] [Abstract][Full Text] [Related]
8. Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.
van Gerven JM; Boot JP; Lemkes HH; van Best JA
Doc Ophthalmol; 1994; 87(4):355-65. PubMed ID: 7851219
[TBL] [Abstract][Full Text] [Related]
9. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
Schalnus R; Ohrloff C
Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
[TBL] [Abstract][Full Text] [Related]
10. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
[TBL] [Abstract][Full Text] [Related]
11. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
Stamper RL; Smith ME; Aronson SB; Cavender JC; Cleasby GW; Fung WE; Becker B
Ophthalmology; 1978 Jun; 85(6):594-606. PubMed ID: 353623
[TBL] [Abstract][Full Text] [Related]
12. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
[TBL] [Abstract][Full Text] [Related]
13. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
Larsen HW; Sander E; Hoppe R
Diabetologia; 1977 Apr; 13(2):105-9. PubMed ID: 323093
[TBL] [Abstract][Full Text] [Related]
14. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.
Benarroch IS; Brodsky M; Rubinstein A; Viggiano C; Salama EA
Ophthalmic Res; 1985; 17(3):131-8. PubMed ID: 4011126
[TBL] [Abstract][Full Text] [Related]
15. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
Adank C; Koerner F
Ophthalmologica; 1985; 190(2):102-11. PubMed ID: 3982791
[TBL] [Abstract][Full Text] [Related]
16. Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation.
Salama Benarroch I; Nano H; Pérez H; Elizalde F; Bisceglia H; Salama A
Ophthalmologica; 1977; 174(1):47-51. PubMed ID: 322009
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of calcium dobesilate in treating Chinese patients with mild-to-moderate non-proliferative diabetic retinopathy (CALM-DR): protocol for a single-blind, multicentre, 24-armed cluster-randomised, controlled trial.
Hu H; Liu J; Wang D; Qiu S; Yuan Y; Wang F; Wen L; Song Q; Sun ZL
BMJ Open; 2021 May; 11(5):e045256. PubMed ID: 34049911
[TBL] [Abstract][Full Text] [Related]
18. Progression of retinopathy and alteration of the blood-retinal barrier in patients with type 2 diabetes: a 7-year prospective follow-up study.
Cunha-Vaz J; Lobo C; Sousa JC; Oliveiros B; Leite E; de Abreu JR
Graefes Arch Clin Exp Ophthalmol; 1998 Apr; 236(4):264-8. PubMed ID: 9561358
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.
Castillo A; Benitez del Castillo JM; Diaz D; Sayagues O; Ruibal JL; Garcia-Sanchez J
Graefes Arch Clin Exp Ophthalmol; 1996 Apr; 234(4):246-50. PubMed ID: 8964530
[TBL] [Abstract][Full Text] [Related]
20. Prevention of diabetic retinopathy.
Einarsdóttir AB; Stefánsson E
Lancet; 2009 Apr; 373(9672):1316-8. PubMed ID: 19376433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
